Compare BCTX & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCTX | AMS |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0M | 14.2M |
| IPO Year | N/A | N/A |
| Metric | BCTX | AMS |
|---|---|---|
| Price | $4.33 | $2.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | ★ 858.8K | 7.7K |
| Earning Date | 03-11-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $29,423,000.00 |
| Revenue This Year | N/A | $3.81 |
| Revenue Next Year | $380.95 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.84 |
| 52 Week Low | $4.10 | $2.01 |
| 52 Week High | $98.20 | $3.21 |
| Indicator | BCTX | AMS |
|---|---|---|
| Relative Strength Index (RSI) | 37.42 | 52.97 |
| Support Level | $4.10 | $2.08 |
| Resistance Level | $4.56 | $2.20 |
| Average True Range (ATR) | 0.71 | 0.05 |
| MACD | -0.25 | -0.00 |
| Stochastic Oscillator | 3.12 | 59.26 |
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.